• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·Switzerland·Industrials·IMPN.SW
Share

Implenia AG Stocks

CHF 71.4Last Updated 29.06.2026

Issuer Rating

5/7
Performance

Favourable

Risk

Limited

Recommendation

Hold

Market Cap

CHF 1.62B

CHF 71.4
Key Takeaways

Risk factor

Low price volatility

Data is available to registered users only
Data is available to registered users only

Profitability factor

Undervalued vs peers

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Implenia AG is a prominent provider of construction and real estate services, primarily serving clients across Switzerland, Germany, Austria, Norway, Sweden, and France, with additional international presence. The company's operations are segmented into four distinct divisions: Real Estate, Buildings, Civil Engineering, and Specialties. Within its Real Estate segment, Implenia offers a comprehensive suite of services encompassing property development, management, and investment; building construction; project leadership; environmental remediation; general and total contracting; building technology solutions; expert real estate consultation; overarching planning; and facilitating home ownership. The Civil Engineering division undertakes a wide array of infrastructure projects, including road construction, tunneling, excavation work, installation of retaining structures, deep foundation construction, noise barrier implementation, general civil engineering tasks, and crucial infrastructure maintenance, alongside structural engineering. Furthermore, its Specialties division delivers specialized construction solutions such as the design and execution of post-tensioning and geotechnical systems, construction logistics management, timber frame construction, mechanical and electrical installations, and advanced material engineering services. Founded in 2006, Implenia AG maintains its corporate headquarters in Dietlikon, Switzerland.

Company Valuation

Undervalued
6/7

From both historical and forecast perspectives, the stock is underpriced compared to similar stocks. In particular, the stock is underpriced on P/E, 'cheap' on EV/EBITDA,

Data is available to registered users only
Sign up to access detailed valuation

Target Price

Somewhat favourable
5/7

The average target price of IMPN.SW is 81 and suggests 12.7% upside potential. Usually, this means a HOLD recommendation among investment firms. This neutral recommendati

Data is available to registered users only
Sign up to access analyst forecasts

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

01.07.2026 20:33

"A Key Source of Value and Risk": Wall Street's Top Tech Optimist Assesses SpaceX

01.07.2026 19:21

Companies laid off employees because of artificial intelligence. Some came to regret it.

01.07.2026 18:59

Meta will launch a cloud infrastructure business. It will compete with Google and Nebius

01.07.2026 18:47

BlackRock is betting on scarce resources in AI supply chains. How should you build your portfolio?

01.07.2026 18:39

Shares of pharmaceutical company Galderma plummeted: The U.S. has halted sales of a Botox generic

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026